- Home
- PAYS vs LUCD Comparison
PAYS vs LUCD Comparison
Compare PAYS & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYS
- LUCD
- Stock Information
- Founded
- PAYS 2001
- LUCD 2018
- Country
- PAYS United States
- LUCD United States
- Employees
- PAYS N/A
- LUCD N/A
- Industry
- PAYS Business Services
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PAYS Consumer Discretionary
- LUCD Health Care
- Exchange
- PAYS Nasdaq
- LUCD Nasdaq
- Market Cap
- PAYS 125.2M
- LUCD 112.5M
- IPO Year
- PAYS 1998
- LUCD 2021
- Fundamental
- Price
- PAYS $5.82
- LUCD $0.97
- Analyst Decision
- PAYS Strong Buy
- LUCD Strong Buy
- Analyst Count
- PAYS 4
- LUCD 4
- Target Price
- PAYS $7.31
- LUCD $3.94
- AVG Volume (30 Days)
- PAYS 1.0M
- LUCD 920.4K
- Earning Date
- PAYS 08-05-2025
- LUCD 08-13-2025
- Dividend Yield
- PAYS N/A
- LUCD N/A
- EPS Growth
- PAYS N/A
- LUCD N/A
- EPS
- PAYS 0.12
- LUCD N/A
- Revenue
- PAYS $68,539,381.00
- LUCD $4,173,000.00
- Revenue This Year
- PAYS $31.28
- LUCD $49.70
- Revenue Next Year
- PAYS $19.36
- LUCD $198.20
- P/E Ratio
- PAYS $43.51
- LUCD N/A
- Revenue Growth
- PAYS 27.84
- LUCD 39.89
- 52 Week Low
- PAYS $1.80
- LUCD $0.73
- 52 Week High
- PAYS $8.88
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- PAYS 33.51
- LUCD 36.74
- Support Level
- PAYS $5.09
- LUCD $0.97
- Resistance Level
- PAYS $7.28
- LUCD $1.11
- Average True Range (ATR)
- PAYS 0.53
- LUCD 0.06
- MACD
- PAYS -0.37
- LUCD -0.01
- Stochastic Oscillator
- PAYS 15.19
- LUCD 21.41
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.